Remove 2019 Remove Immunization Remove Labelling
article thumbnail

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

Image Credit: sonyakamoz - stock.adobe.com "We have been conditioned to equate weight loss with health, and weight loss-resistant individuals are often labeled as failures,” Anat Yaskolka Meir, PhD, postdoctoral research fellow in the department of epidemiology at Harvard Chan School, said in a news release. Updated July 15, 2019.

article thumbnail

Positive safety data for long-term use of MS drug Kesimpta

pharmaphorum

The findings were based on an ALITHIOS Phase 3b open-label extension study of Kesimpta, a targeted B-cell therapy that Novartis says, “delivers superior efficacy with a similar safety and tolerability profile compared with teriflunomide, a first-line treatment for MS.”. billion in 2019. years vs initiation two years later.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BMS scores first approval for psoriasis therapy Sotyktu

pharmaphorum

Bristol-Myers Squibb’s deucravacitinib– one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe plaque psoriasis. billion oral psoriasis therapy Otezla (apremilast). Otezla was acquired by Amgen for $13.4

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5

article thumbnail

Does Rinvoq cause weight gain?

The Checkup by Singlecare

It’s part of the immune system’s defense mechanism, but it can cause serious issues—like rheumatoid arthritis and psoriatic arthritis—if it gets too severe. Rinvoq is a Janus kinase (JAK) inhibitor, which means it blocks certain enzymes that cause the immune system to create inflammation. Inflammation is a double-edged sword.

article thumbnail

The Connection Between UTIs and Hashimoto’s

The Thyroid Pharmacist

Additionally, high blood sugar can impair immune function, making it harder for the body to fight off infections. Takeaway Supporting a healthy gut microbiome may help reduce UTIs and also promote better thyroid function and immune balance in autoimmune conditions! Published 2019 May 2. Ther Adv Urol. 2019;11:1756287219832172.

article thumbnail

Pharming preps filing for rare disease drug leniolisib after trial win

pharmaphorum

The Netherlands biotech is developing leniolisib (formerly CDZ173) under license from Novartis for activated PI3K delta syndrome (APDS), an ultra-rare disease with no approved therapies that causes severe immune deficiency and a risk of blood cancers.